294. 先天性横隔膜ヘルニア Disease details / Clinical trials / Drug dev / DR info

Autologous umbilical cord blood
   The University of Texas Health Science Center, Houston
      2018   Phase 1   NCT03526588   United States
Blood sample
   Assistance Publique - Hôpitaux de Paris
      2014   -   NCT02175264   France
Bronchodilator response
   The Hospital for Sick Children
      2012   -   NCT02453750   Canada
DE-implementation OF inhaled nitric oxide (INO) USE
   The University of Texas Health Science Center, Houston
      2025   Phase 4   NCT05213676   United States
Fecal microbiome probiotic
   Medical University of Graz
      2018   -   NCT03787160   Austria
Functional residual capacity
   Medical University of Graz
      2018   -   NCT03787160   Austria
Hypersaline
   The Hospital for Sick Children
      2012   -   NCT02453750   Canada
Inalossin - 800 PPM MOL/MOL GAS medicinale compresso bombola IN alluminio CON valvola VI DA 20 litri
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden
Inalossin 800 PPM MOL/MOL GAS medicinale compresso
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden
Initial fecal microbiome
   Medical University of Graz
      2018   -   NCT03787160   Austria
Initial pulmonary microbiome
   Medical University of Graz
      2018   -   NCT03787160   Austria
Initial VOC
   Medical University of Graz
      2018   -   NCT03787160   Austria
Inomax 800PPM MOL/MOL inhalatiegas
   Erasmus MC
      2019   Phase 3   EUCTR2017-000421-13-BE   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2018   Phase 3   EUCTR2017-000421-13-NO   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2018   Phase 4   EUCTR2017-000421-13-AT   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2017   Phase 3   EUCTR2017-000421-13-NL   Austria;Belgium;Netherlands;Norway;Sweden
      -   Phase 3   EUCTR2017-000421-13-SE   Austria;Belgium;Netherlands;Norway;Sweden
Lipid injectable emulsion with fish OIL
   Coordinación de Investigación en Salud, Mexico
      2019   Phase 2   NCT04031508   Mexico
Losec
   ErasmusMC
      2013   -   EUCTR2013-002026-22-NL   Netherlands
Maximum oxygen uptake
   Medical University of Graz
      2018   -   NCT03787160   Austria
Milrinone
   NICHD Neonatal Research Network
      2017   Phase 2   NCT02951130   United States
Neophyr 1000PPM MOL/MOL
   Erasmus MC
      2019   Phase 3   EUCTR2017-000421-13-BE   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2018   Phase 3   EUCTR2017-000421-13-NO   Austria;Belgium;Italy;Netherlands;Norway;Sweden
Nitric oxide
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden
   Erasmus MC
      2019   Phase 3   EUCTR2017-000421-13-BE   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2018   Phase 3   EUCTR2017-000421-13-NO   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2018   Phase 4   EUCTR2017-000421-13-AT   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      -   Phase 3   EUCTR2017-000421-13-SE   Austria;Belgium;Netherlands;Norway;Sweden
Omeprazol
   ErasmusMC
      2013   -   EUCTR2013-002026-22-NL   Netherlands
Omeprazole rectally 1MG/KG
   Rijnstate Hospital
      2005   Phase 3   NCT00226044   Netherlands
Ossido DI azoto
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden
Probiotic treatment
   Medical University of Graz
      2018   -   NCT03787160   Austria
Pulmonary microbiome probiotic
   Medical University of Graz
      2018   -   NCT03787160   Austria
Repair OF CDH W/alloderm
   Children's Mercy Hospital Kansas City
      2005   Phase 3   NCT00257946   United States
Repair OF CDH W/SIS gold
   Children's Mercy Hospital Kansas City
      2005   Phase 3   NCT00257946   United States
Revatio - 0.8 MG/ML - soluzione iniettabile - USO endovenoso - flaconcino(vetro) 1 flaconcino DA 20 ML
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden
Revatio 0.8MG/ML solution FOR injection
   Erasmus MC
      2019   Phase 3   EUCTR2017-000421-13-BE   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2018   Phase 3   EUCTR2017-000421-13-NO   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2018   Phase 4   EUCTR2017-000421-13-AT   Austria;Belgium;Italy;Netherlands;Norway;Sweden
      2017   Phase 3   EUCTR2017-000421-13-NL   Austria;Belgium;Netherlands;Norway;Sweden
      -   Phase 3   EUCTR2017-000421-13-SE   Austria;Belgium;Netherlands;Norway;Sweden
Sildenafil
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden
   Erasmus MC
      2018   Phase 4   EUCTR2017-000421-13-AT   Austria;Belgium;Italy;Netherlands;Norway;Sweden
   Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
      2020   Phase 0   ChiCTR2000037331   China
Sildenafil oral suspension
   University of Utah
      2022   Phase 2   NCT05201144   United States
VOC probiotic
   Medical University of Graz
      2018   -   NCT03787160   Austria